The FDA is seeking public feedback on plans to tailor [...]

A US observational study of nearly 7,000 adults with HIV-1 [...]

AmplexDiagnostics has launched a CE-IVD molecular diagnostic test that detects [...]

SeaBeLife has secured €2.9 million in French government funding to [...]

Gesynta Pharma has completed recruitment for its Phase 2 trial [...]

AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

Nearly half of surveyed patient groups say they engage with [...]

Johnson & Johnson has reported three-year clinical remission data for [...]

NICE has recommended maralixibat for cholestatic pruritus caused by Alagille [...]

Mursla Bio has published peer-reviewed data showing that isolating liver-derived [...]